Fabtech Technologies Secures USD 7 Million Contract in West Africa
Filing Summary
Fabtech Technologies Ltd has announced the receipt of a significant order from a company in West Africa. The contract, valued at approximately USD 7,050,000, involves the supply, installation, and commissioning of an Oral Solid Dosage (OSD) facility. The execution period for this international contract is set between 23 to 27 months from the receipt of the advance payment. The customer’s identity remains confidential due to privacy obligations. This development was disclosed in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements.
Fabtech Technologies Ltd has informed the National Stock Exchange of India Limited and BSE Limited about securing a new order from a company in West Africa. The order was received on February 14, 2026, as per the filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The contract involves the supply, installation, and commissioning of an Oral Solid Dosage (OSD) facility. The total consideration for this international contract is approximately USD 7,050,000, which is equivalent to about Rs. 63.6 Crores. The execution timeline for the project is set between 23 to 27 months from the date of receiving the advance payment.
The identity of the customer in West Africa is not disclosed due to confidentiality obligations. The filing confirms that there is no interest from the promoter or promoter group in the entity awarding the contract, and the transaction does not fall under related party transactions.
Fabtech Technologies Ltd specializes in providing engineering solutions for the pharmaceutical industry. The company focuses on delivering turnkey projects and innovative solutions to enhance pharmaceutical manufacturing capabilities globally.